Stay Updated with the Latest Hardwyn India Limited HARDWYN.NS News in Real Time
Find HARDWYN.NS news now at Meyka AI. Stay informed with the latest Hardwyn India Limited stocks updates, including price news, market analysis, and expert insights.
Mizuho Sues Radiant World in Singapore Court as Police Probe Widens
Singapore police raid Radiant World’s office investigating falsified documents. Mizuho Bank files court injunction against the iron ore trader on August 28 as five banks discover fake invoices.
Yamaha R2 Launches in India at ₹2.30 Lakh on August 27
Yamaha launches YZF-R2 in India at ₹2.30 lakh with 204cc engine, 26.5 PS power, and three variants. Deliveries begin mid-September 2026. Competes with KTM RC 200.
Yash’s Toxic Hits Rs 140 Crore Gross on Day 1, Then Loses Steam on Day 2
Yash’s Toxic opens with Rs 101.10 crore net on Day 1, one of India’s biggest openers, but drops 84% on Day 2 to Rs 16.48 crore as mixed reviews and trolls emerge.
Hyperliquid Surges 3.2% to $85.08 as Tokenized Stocks Launch Drives Volume
HYPEUSD rallied 3.2% to $85.08 on August 27 following Hyperliquid’s launch of tokenized stocks and AQAv2 buyback engine on August 26.
Sonal Dinusha Scores Twin Centuries vs India, Joins Elite Test Club on August 27
Sonal Dinusha scores 103 and 133* in Colombo Test, becoming third batter ever to score centuries in both innings after follow-on. Sri Lanka draws 2nd Test vs India.
Nepal Floods Kill 359 as Glacier Collapse Triggers Himalayan Disaster; 34 Australians Missing
Glacier collapse in Nepal Himalayas triggers deadly flash floods killing 359 people. 34 Australians among nearly 1,500 missing as rescue efforts continue across Nepal-Tibet border.
AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial
AstraZeneca said Thursday its drug Tezspire met all primary and secondary goals in a late-stage trial. The Phase III CROSSING trial tested Tezspire against placebo in eosinophilic oesophagitis (EoE). AstraZeneca developed the drug jointly with Amgen for this chronic inflammatory oesophagus condition. What the CROSSING Trial Showed The Phase III CROSSING trial evaluated two once-every-four-week…
Nvidia Beats Q2 Targets With $96.2B Revenue, Stock Falls 1.6% on August 27
Nvidia beat Q2 earnings with $96.2B revenue and $2.22 adjusted EPS, but stock fell 1.6%. Q3 guidance of $108B signals strong AI chip demand ahead.
Nepal Floods Kill 160+, Five Japanese Missing as Glacial Collapse Triggers Disaster
Nepal flash floods kill 160+ people, leave 1,400 missing including five Japanese. Glacial collapse triggered disaster on Nepal-China border affecting hikers and pilgrims.